Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selection.
Borque-Fernando Á, Zapatero A, Manneh R, Alonso-Gordoa T, Couñago F, Domínguez-Esteban M, López-Valcárcel M, Rodríguez-Antolín A, Sala-González N, Sanmamed N, Maroto P; en representación del Grupo Guard de Investigación Multidisciplinar en Tumores genitourinarios. Borque-Fernando Á, et al. Among authors: sanmamed n. Actas Urol Esp (Engl Ed). 2024 May 11:S2173-5786(24)00068-4. doi: 10.1016/j.acuroe.2024.05.008. Online ahead of print. Actas Urol Esp (Engl Ed). 2024. PMID: 38740263 English, Spanish.
MR-LINAC, a New Partner in Radiation Oncology: Current Landscape.
Ocanto A, Torres L, Montijano M, Rincón D, Fernández C, Sevilla B, Gonsalves D, Teja M, Guijarro M, Glaría L, Hernánz R, Zafra-Martin J, Sanmamed N, Kishan A, Alongi F, Moghanaki D, Nagar H, Couñago F. Ocanto A, et al. Among authors: sanmamed n. Cancers (Basel). 2024 Jan 8;16(2):270. doi: 10.3390/cancers16020270. Cancers (Basel). 2024. PMID: 38254760 Free PMC article. Review.
Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trial.
Sanmamed N, Adleman J, Berlin A, Borg J, Lao B, Weersink R, Simeonov A, Rink A, Beiki-Ardakani A, Menard C, Chung P, Helou J. Sanmamed N, et al. Brachytherapy. 2023 Jan-Feb;22(1):58-65. doi: 10.1016/j.brachy.2022.08.015. Epub 2022 Nov 19. Brachytherapy. 2023. PMID: 36414526 Clinical Trial.
Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I-II trial.
Sanmamed N, Alcantara P, Gómez S, Bustos A, Cerezo E, Gaztañaga M, Doval A, Corona J, Rodriguez G, Cabello N, Duffort M, Ortuño F, de Castro J, López A, Fuentes M, Sanz A, Vazquez M. Sanmamed N, et al. Radiother Oncol. 2022 Jun;171:25-29. doi: 10.1016/j.radonc.2022.03.015. Epub 2022 Mar 31. Radiother Oncol. 2022. PMID: 35367528 Free PMC article. Clinical Trial.
Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report.
Sanmamed N, Alcantara P, Cerezo E, Gaztañaga M, Cabello N, Gómez S, Bustos A, Doval A, Corona J, Rodriguez G, Duffort M, Ortuño F, de Castro J, Fuentes ME, Sanz A, López A, Vazquez M. Sanmamed N, et al. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):880-885. doi: 10.1016/j.ijrobp.2020.11.049. Epub 2020 Nov 26. Int J Radiat Oncol Biol Phys. 2021. PMID: 33249142 Free PMC article. Clinical Trial.
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life.
Sanmamed N, Lee J, Berlin A, Craig T, Lao B, Rink A, Bayley A, Catton C, Sundaramurthy A, Foltz W, McPartlin A, Ghai S, Astenafu E, Gospodarowicz M, Warde P, Ménard C, Chung P. Sanmamed N, et al. Radiother Oncol. 2020 Aug;149:240-245. doi: 10.1016/j.radonc.2020.05.029. Epub 2020 May 22. Radiother Oncol. 2020. PMID: 32447033
15 results